Title:
FXA PROTEIN FOR TREATING AND/OR PREVENTING COVID-19
Document Type and Number:
WIPO Patent Application WO/2022/236176
Kind Code:
A3
Abstract:
Provided herein are, inter alia, methods and compositions useful for treating or preventing COVID-19 in a subject in need thereof. The compositions include Factor Xa (FXa) protein or functional portion thereof. The compositions may further include an anticoagulant, particularly an indirect inhibitor of FXa.
Inventors:
YU JIANHUA (US)
CALIGIURI MICHAEL (US)
CALIGIURI MICHAEL (US)
Application Number:
PCT/US2022/028358
Publication Date:
December 22, 2022
Filing Date:
May 09, 2022
Export Citation:
Assignee:
HOPE CITY (US)
International Classes:
A61K38/36; A61P31/14; C12N9/64
Domestic Patent References:
| WO2020079155A1 | 2020-04-23 |
Foreign References:
| US20120244139A1 | 2012-09-27 | |||
| US20110236474A1 | 2011-09-29 | |||
| US20190309279A1 | 2019-10-10 |
Attorney, Agent or Firm:
CHEN, Yuwei et al. (US)
Download PDF:
Previous Patent: INFANT 2D POSE ESTIMATION AND POSTURE DETECTION SYSTEM
Next Patent: LED RETROFIT FOR VEHICLE LIGHTING
Next Patent: LED RETROFIT FOR VEHICLE LIGHTING